Role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells. The current study was designed to test the role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity, and to determine whether it may serve as a source of catalytic iron. Hydrogen peroxide led to iron release (as measured by iron/bathophenanthroline complex) from the microsomes prepared from LLC-PK1 cells. Cimetidine, which inhibits cytochrome P-450 by interacting with the heme iron, significantly blocked iron release, whereas ranitidine, which has a similar structure as cimetidine but is a weak inhibitor of P-450, did not have an effect (H,07, 0.42 0.04; H2O + cimetidine, 0.23 0.02 nmol/mg protein; N = 4, P < 0.01). Exposure of LLC-PK1 cells to hydrogen peroxide (2.5 mM) resulted in a significant increase in the bleomycindetectable iron (iron capable of catalyzing free radical reactions) content that was prevented by cimetidine, but not ranitidine. We then examined the effect of the inhibitors of cytochrome P-450 on cell death (as measured by Trypan blue exclusion) after exposure of LLC-PK1 cells to 2.5 mM hydrogen peroxide for 120 minutes. Inhibition of eytoehrome P-450 by cimetidine significantly reduced the cell death; the effect was observed with 0.05 m and was concentration dependent with 1 mM affording almost complete protection (H20,, 59 1.3% vs. H207 + cimetidine, 11 0.7%; N = 5, P < 0.01). In contrast, ranitidine did not show any protection. We confirmed that the protective effect of cimetidine was not related to scavenging hydrogen peroxide or hydroxyl radicals or chelating iron. A second inhibitor of eytochrome P-450, piperonyl hutoxide, had a similar dose-dependent beneficial effect against hydrogen peroxide-induced cell injury. Our data thus indicate an important role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells and suggest that cytochrome P-450 may serve as a source of catalytic iron.
Reactive oxygen metabolites are important mediators of ischernie, toxic and immune-related tissue injury [1] . Recent studies have implicated their role in the pathophysiology of several models of acute renal failure [2] [3] [4] [5] [6] [7] [8] . Irreversible tubular injury is a striking feature of acute renal failure and histological studies have shown that the renal tubular epithelial cells are the major site of injury in each of these models of acute renal failure [3, 9, 101. The ability of oxidants to induce loss of cell viability in renal tubular cells has recently been reported . Hydrogen peroxide is the major reactive oxygen metabolite responsible for tissue injury [101, presumably because hydrogen peroxide is both stable and able to freely penetrate cellular targets, where it may he Received for publication January 18, 1996 and in revised form April 2, 1996 Accepted for publication May 16, 1996 © 1996 by the International Society of Nephrology toxic by itself or through the generation of other reactive oxygen metabolites. Indeed, we have shown that the marked loss of cell viability in LLC-PK1 cells, on exposure to hydrogen peroxide (generated by glucose/glucose oxidase) is markedly reduced by iron chelators [12] .
The source of this iron that participates in hydrogen peroxide mediated cellular injury is not known. Iron storage protein ferritin, iron-rich mitochondria, and under certain circumstances, extracellular heme protein such as hemoglobin and myoglobin have all been suggested as possible sources for this iron [4, 14-171. Several recent studies indicate that the iron rich enzyme, cytochrome P-450, may serve as a source of iron in tissue injury [18, 19] . The role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity has not been previously examined. Hence, the current study was designed to test the role of cytochrome P-450 in hydrogen peroxide-induced eytotoxicity to LLC-PK1 cells and to examine the possibility that cytochrome P-450 may serve as a source of catalytic iron.
Methods
Cell culture LLC-PK1 cells purchased from American-Type Culture Collec tion (CRL 1392), were maintained in Medium 199 supplemented with 3% fetal bovine serum and penicillin (100 U/mI) in a humidified atmosphere of 95% air-5% CO2. Confluent mono layers were subcultured using 0.05% trypsin, 0.53 mvi EDTA in calcium and magnesium free Hank's balanced salt solution. The medium was changed twice a week and all experiments were carried out on cell cultures two days post-confluency, between passages 199 to 220.
Microsome preparation
Microsomes from LLC-PK1 cells were isolated as described by Guzelian, Bissell and Meyer [20] . Confluent cell monolayer was washed free of medium with 0.1 M potassium phosphate buffer (pH 7.4) and sonieated for 10 seconds. The sonicate was then centrifuged at 10,000 g for 20 minutes. The resulting supernatant was centrifuged in a Beckman L-2 ultracentrifuge at 105,000 g at 4°C for 60 minutes. The microsomal pellet was resuspended in 50 mM NaCl-20% glycerol, pH 7.0 [21] .
Iron mobilization from microsomal fraction Release of iron from microsomal fraction was measured using a method described by Ulvik and Romslo [22] and modified by Minotti [21] and utilized in our previous study [171. Briefly, microsome (1 mg protein/mi), ADP (1 mM), bathophenanthroline disulfonic acid (BPS) and test agents were incubated in 50 mi NaC1, pH 7.0 (2 ml, final volume) at 37°C for 60 minutes. The amount of iron released was determined using the extinction coefficient for the Fe2 -BPS complex (E = 22.14 m cm1 at A530 nm).
Effect of hydrogen peroxide on catalytic iron LLC-PK1 cells were incubated with 2.5 m'vi H20, in chelex 100 resin treated HBSS. After 60 minutes 2000 U/mI of catalase was added to stop the reaction and the incubation medium was collected for the measurement of bleomycin-detectable iron. To examine the effect of cytochrome P-450 on iron release, LLC-PK1 cells were preincubated with cimetidine (1 mM) or ranitidine (0.3 mM) in medium 199 devoid of serum and penicillin at 37°C for 60 minutes. The cells were then washed three times with chelexed HBSS prior to incubating with hydrogen peroxide.
Iron capable of catalyzing free radical reactions was measured by the bleomycin assay developed by Gutteridge and Hou [23] as utilized in our previous study [24] and modified by Zager [25] . All reagents except for the sample under test were made up in chelex-treated pyrogen-free water in plastic containers and shaken with chelex-100 to remove as much contaminating iron as possible. The reaction mixture contained in order: 0.5 ml of calf thymus DNA (1 mg/mI), 0.1 ml of bleomycin sulfate (0.1 U/ml), 0.1 ml of MgCI2 (50 mM), 0.1 ml of imidazole (1.0 M, pH 7.3), 0.1 ml of sample, and 0.1 ml of ascorbic acid (8 mM). Tubes were mixed well and then incubated at 37°C for two hours with shaking. The reaction was stopped by the addition of 0.1 ml EDTA (0.1 M) and developed with 1.0 ml of thiobarbituric acid (1% wt/vol in 50 mM NaOH) and 1.0 ml HCI (25%, vol/vol). This reaction mixture was then heated at 100°C for 10 minutes, cooled, and read at A532 nm. Bleomycin-detectable iron was calculated from a standard curve (0 to 10 fLM of FeCI3 in chelex-treated pyrogen free water). Trypan blue exclusion assay [13] . In brief, 7 1J of 4% Trypan blue was added to 90 d of the cell suspension and examined using a hemacytometer under light microscopy. Cells failing to exclude the dye were considered non-viable, and the data expressed as the percentage of non-viable cells. LDH release was measured as previously described [26] .
Inhibition of cytochrome P-450 Two different inhibitors of cytochrome P-450 were used. Cimetidine has imidazole and cyano groups that inhibit cytochrome P-450 by interacting with the heme iron [271. This effect of cimetidine is specific for P-450 as it does not interact with other heme enzymes [28] . As a control for cimetidine, ranitidine, which has three times the H2-receptor blocking activity as cimetidine, inhibits cytochrome P-450 either weakly or not at all [27, 29] .
Piperonyl butoxide, on the other hand, yields a metabolite that binds to heme iron of cytochrome P-450 [30, 31] . To determine the effect of cytochrome P-450 inhibition on hydrogen peroxideinduced cell injury in LLC-PK1 cells, the cell suspensions were preincubated with various concentrations of cimetidine, ranitidine or piperonyl butoxide for 30 minutes, and then incubated with 2.5 m hydrogen peroxide at 37°C for 120 minutes. Cytotoxicity was measured by Trypan blue exclusion as described above.
Measurement of hydroxyl radical formation, hydrogen peroxide, and iron
Hydroxyl radical formation in a cell free system was measured by deoxyribose degradation method described by Halliwell, Grootveid and Gutteridge [321. Briefly, 10 pA of the test agent was mixed with 10 1d of 2-deoxy-D-ribose (300 mM), 10 pA of ferrous ammonium sulfate (10 mM) and 10 pA of hydrogen peroxide (100 mM), and made up to I ml of total volume with 10 mM phosphate buffer (pH 7.4). The solution was incubated at 37°C for 60 minutes. After incubation, the reagents were mixed with I ml of 1% (wt/vol) solution of thiobarbituric acid in 50 mivi NaOH and I ml of 2.8% (wt/vol) aqueous trichioroacetic acid, heated at 100°C for 15 minutes, cooled, and then read at 532 nm.
To examine whether cimetidine scavenges hydrogen peroxide, a known amount of hydrogen peroxide (3 mM) was preincubated with various concentrations of cimetidine (0.1 to 1 mM) for 30 minutes, and then the concentration of hydrogen peroxide was measured by the phenol red assay [331. Briefly, 10 jLl of sample or standard solution was added to 1 ml of buffered phenol red solution (0.28 m phenol red, 8.5 U/mi horseradish peroxidase, 5.5 m dextrose, 10 m potassium phosphate buffer, pH 7.0, 140 mM NaCI), and incubated for five minutes at room temperature. The reaction mixture was then brought to pH 12.5 using 10 pA of 1 N NaOH and the absorbance read at 610 nm. The amount of hydrogen peroxide was determined using a standard curve prepared with 30% hydrogen peroxide solution.
To determine whether cimetidine chelates iron, a known amount of iron (145 xM) was preincubated with various concentrations of cimetidine (0.1 to 1 mM) for 30 minutes, and then the nonheme iron assay was performed as described by Torrance and Bothwell [34] . In brief, 0.1 ml of the sample or standard solution was mixed with I ml of chromogen reagent (0.37 m'vi BPS and 28.6 mM thioglycolic acid) for 10 minutes at room temperature. The absorbance was read at 532 nm against a reagent blank and the amount of iron was determined using a standard curve prepared with ferrous ammonium sulfate. Similarly, the effect of cimetidine on the recovery of bleomycin-detectabie iron was examined. A known amount of iron (FeCl3, 1 nmol/ml) was preincubated in the absence or presence of cimetidine (0.1 to 1 mM) for 30 minutes, and then the bleomycin assay was performed.
Cytochrome P-450 activity Cytochrome P-450 activity was assessed by p-nitroanisole demethyiase as described by Bissell, Hammaker and Meyer [35] . In brief, the LLC-PK1 cell monolayer was sonicated and centrifuged at 18,000 g at 4°C for 10 minutes. Assay for the o-demethylase activity was carried out on the supernatant with p-nitroanisoie as substrate. The reaction mixture contained 10 mvi MgCI2, 5 mM glucose-6-phosphate, 2 U/mI glucose-6-phosphate dehydrogenase, 0.4 mMp-nitroanisoie, 0.5mM NADPH and 1 mg protein/mi of the supernatant, and made up with 100 mM potassium phosphate buffer, pH 7.25, to a total volume of 1 ml. The absorbance change was monitored at 405 to 490 nm and the activity of the enzyme was calculated using an extinction coefficient of 12.87 m1 cm.
Statistical analysis
Values are expressed as mean standard error (Sc). Statistical analyses was performed using unpaired t test (for only 2 groups) and analysis of variance (for more than 2 groups). Statistical significance was considered at P value < 0.05.
Materials
Tissue culture supplies were purchased from Gibco (Grand Island, NY, USA). Cimetidine was obtained from SmithKline Beecham Pharmaceuticals (Philadelphia, PA, USA). Ranitidine was from Glaxo Pharmaceuticals (Research Triangle Park, NC, USA). Piperonyl butoxide was from Aldrich Chemical Company, Inc. (Milwaukee, WI, USA). All other chemicals werc purchased from Sigma (St. Louis, MO, USA).
Results
To examine the possibility that cytochrome P-450 may serve as a source of iron, we first examined the effect of hydrogen peroxide on the iron release from the microsomes prepared from LLC-PK1 cells. Hydrogen peroxide led to an iron release as measured by Fe2-(BPS)1 from the microsome (control, 0.12 0.01, 2.5 mvt; H202, 0.42 0.04 nmol/mg protein; N = 4, P < 0.01). If the heme moiety of cytochrome P-450 were the source of this iron then cimetidine, which inhibits cytochrome P-450 by interacting with the heme iron [28] , should prevent the release of iron. We therefore examined the effect of cytochrome P-450 inhibitor on iron mobilization from the microsomes. As shown in Figure 1 , the increase in iron mobilization was significantly blocked by cimetidine (P < 0.01), but not by ranitidine.
Most of the iron is bound to heme and non-heme proteins, and does not directly catalyze the generation of hydroxyl radicals or a similar oxidant [361. Gutteridge et al have described an assay based on the use of the antibiotic, bleomycin, to detect iron complexes capable of catalyzing free radical reactions in biological samples [36.-39J. We examined whether iron capable of catalyzing free radical reactions (the bleomycin-detectable iron) is increased on exposure of LLC-PK1 cells to hydrogen peroxide. We also examined the effect of inhibitors of cytochrome P-450. Exposure of LLC-PK1 cells to hydrogen peroxide (2.5 mM) resulted in a significant increase in the bleomycin-detectable iron content (Fig.  2) . Cimetidine (CM, 1 mM), a P-450 inhibitor, but not ranitidine (RN, 0.3 mM), which has a similar structure as CM but is a weak inhibitor of P-450, prevented this marked increase in the bleomycm-detectable iron content (Fig. 2) .
We then examined the role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells. As shown in Figure 3 , hydrogen peroxide was cytotoxic to LLC-PK1 cells in a time and dose dependent manner as measured by Trypan blue exclusion. Based on these studies we then examined the effect of the inhibitors of cytochrome P-450 after exposure of LLC-PK1 cells to 2.5 m of hydrogen peroxide for 120 minutes. Inhibition of cytochrome P-450 by cimetidine significantly reduced the cell injury induced by hydrogen peroxide (Fig. 4A) . The effect was observed with 0.05 m and was concentration dependent with 1 ifiM affording almost complete protection. In contrast, ranitidine, which has three times the H2-receptor blocking activity as cimetidine but is a weak inhibitor of cytochrome P-450, did not show any protection when used in the same concentrations as cimetidine (Fig. 4A) . We also examined the effect of cimetidine on 2, N = 5, P < 0.Olj. In addition, we also examined the effect of cimetidine on Triton-induced loss of cell viability as previously described [401. Treatment of LLC-PK1 cells with 0.005% Triton X-100 in serum-free DMEM for 60 minutes resulted in significant cell death, as measured by Trypan blue exclusion, and cimetidine failed to afford any protection against cell death (control vs, Triton-treated, N = 3, P < 0.01), indicating that the effect of cimetidine was not a nonspecific effect. We also confirmed that the addition of cimetidine (1 mM) after cell death did not interfere with the Trypan blue exclusion (data not shown).
In a separate experiment, we confirmed the inhibition of cyto- chrome P-450 as measured by p-nitroanisole demethylase (control, 0.17 0.03; 1 mrvt cimetidine, 0.04 0.04 nmol!mg protein! mm; N = 4, P < 0.05). A second inhibitor of cytochrome P-450, piperonyl butoxide, had a similar dose-dependent beneficial effect against hydrogen peroxide-induced cell injury (Fig. 4B) .
We considered the possibility that the observed beneficial effects of the. cytochrome P-450 may he due to its ability to scavenge hydrogen peroxide. Cimetidine in concentrations between 0.1 and 1 m'vi did not scavenge hydrogen peroxide (Fig.  5A) . We also confirmed that cimetidine did not chelate iron. In these studies we found that the amount of non-heme iron (Fig.  SB) or bleomycin-detectable iron (Fig. SC) was not altered by addition of cimetidine in concentrations between 0.1 and 1 m. In Values are means SE; N = 6. P < 0.01 compared with control.
tion. As shown in Figure 6 , the reaction was inhibited by catalase, an iron chelator (deferoxamine), and hydroxyl radical scavengers, mannitol and DMSO. Superoxide dismutase had no effect, thus indicating that the hydroxyl radical formation was dependent on hydrogen peroxide and iron. Both inhibitors of cytochrome P-450, cimetidine and piperonyl butoxide, did not scavenge hydroxyl radical formation. Taken together, these data suggest that the protective effect of cytochrome P-450 inhibitor on hydrogen peroxide-induced cell injury is unlikely to be the result of scav--enging hydroxyl radical or hydrogen peroxide or chelating iron.
Discussion
The role of cytochrome P-450 in hydrogen peroxide-mediated cytotoxicity has not been previously examined. Our results indicate that prior treatment of the cells with P-450 inhibitors resulted in a marked preservation of cell viability against hydrogen perox. ide-induced cytotoxicity. Ranitidine, which has three times the H7-receptor blocking activity as cimetidine but is a weak inhibitor of P-450, did not exhibit any protection. To increase the specificity of our observation, two chemically distinct inhibitors of cytochrome P-450 were used. We also confirmed that the protective The mechanism(s) by which cytochrome P-450 mediates hydrogen peroxide cytotoxicity in LLC-PK1 cells is not known. However, cytochrome P-450 has been suggested by Bysani et a! as a source of iron in reperfusion injury to the rabbit lung [18] , and more recently by Paller and Jacob to the kidney [19j. Our data provide evidence that cytochrome P-450 may serve as a significant source of iron capable of catalyzing free radical reactions in hydrogen peroxide-mediated injury to LLC-PK1 cells. In our study, exposure of microsomal fraction from LLC-PK1 cells to hydrogen peroxide led to a release of iron. This release was prevented by cimetidine, which has imidazole and cyano groups that interact with the heme iron of cytochrome P-450 rendering it unavailable [271. In contrast, ranitidine, a weak inhibitor of cytochrome P-450 [27, 291, had no effect, which suggests cytochrome P-450 as the source of iron. Exposure of LLC-PK cells to hydrogen peroxide also resulted in a significant increase in the bleomycin-detectable (iron capable of catalyzing free radical reactions) iron content that was prevented by cimetidine but not ranitidine. Based on the ability of cytochrome P-450 inhibitors to prevent iron release from microsomal fraction isolated from LLC-PK1 cells, as well as decreasing catalytic iron content after exposure to hydrogen peroxide, suggests that cytochrome P-450 serves as a significant source of catalytic iron in hydrogen peroxide-induced cytotoxicity. It appears likely that hydrogen peroxide could lead to a direct oxidative attack on the heme moiety of cytochrome P-450, resulting in the release of iron from the labile heme chelate [16, 36] . In the present study we have not excluded the possibility that iron from other sources may also play a role in this model of cytotoxicity.
Several previous studies have examined the potential mechanisms by which catalytic iron plays a role in renal tubular epithelial cell injury. In our previous study we have shown that iron chelators provide significant protection against hydrogen peroxide-induced DNA damage [111. In other prior studies we also demonstrated an important role of intracellular calcium [41] and an important role of calcium dependent endonuclease in oxidantinduced damage to LLC-PK1 cells [421. The demonstration in our subsequent study that iron chelators prevented an oxidant induced increase in intracellular calcium suggests that the effect of iron chelators in preventing oxidant-induced DNA damage may be due, at least in part, to the prevention of oxidant-induced rise in intracellular calcium [111. The effect of cytochrome P-450
inhibitors on this variety of processes affected by catalytic iron has not been examined. Our data thus indicate an important role of cytochrome P-450 in hydrogen peroxide-induced cytotoxicity to LLC-PK1 cells.
Although we have previously shown that iron plays a critical role in hydrogen peroxide-mediated cytotoxicity to LLC-PK1 cells, the intracellular source of this iron was not known [13] . The results of the present study suggest that cytochrome P-450 may serve as a source of iron in oxidant injury in various tissues.
